BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DEMENTIA RESEARCHER - ECPv6.14.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DEMENTIA RESEARCHER
X-ORIGINAL-URL:https://www.dementiaresearcher.nihr.ac.uk
X-WR-CALDESC:Events for DEMENTIA RESEARCHER
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251203
DTEND;VALUE=DATE:20251206
DTSTAMP:20260620T055029
CREATED:20251029T130048Z
LAST-MODIFIED:20251029T130048Z
UID:10001979-1764720000-1764979199@www.dementiaresearcher.nihr.ac.uk
SUMMARY:Qualitative Methods in Clinical Trials
DESCRIPTION:The course introduces the key considerations when using qualitative methods in clinical trials. Throughout the three-day course\, delegates will learn about the theory\, relevance and value of qualitative research in all stages of a clinical trial as well as gain an appreciation of different types of qualitative methodology used in clinical trials. We will primarily focus on clinical trials but will also consider qualitative research as part of feasibility studies that can be used to test interventions in preparation for a large clinical trial.  \nBy the end of the course\, participants should: \n\nUnderstand how qualitative research can complement trial methodology at all stages of clinical trials\nAppreciate specific methodological issues such as ethical requirements and sampling challenges when designing qualitative research\nAppreciate how to generate\, manage and analyse qualitative data in a clinical trial\nUnderstand reporting requirements for qualitative research conducted as part of a clinical trial\n\nThe course will incorporate a range of activities (individual\, didactic\, and small group) and discussion to allow students to practice and enact learning. \nThe course is intended for anyone seeking an introductory course on the use of qualitative research in clinical trials including the theory\, relevance and value in all stages of clinical trials. \nThe course will comprise of lectures\, activities (individual\, didactic and small group) and discussion. \nExact timing and further details will be provided nearer the time\, though days will usually start around 09.00 and end at 16.30. \n\n\nCourse tutors\n\n\n\nPaul Leighton – Associate Professor in Health Services Research at the Centre of Evidence Based Dermatology \nKirsty Sprange – Assistant Professor of Clinical Trials at the Nottingham Clinical Trials Unit \nLouise Thompson – Associate Professor in Occupational Psychology\, Centre for Organisational Health and Development \nRachel Evley – Senior Qualitative Advisor in the NIHR Research Support Service and an Honorary Associate Professor in Anaesthesia & Critical Care \n\n\nCost\n\n\n\nEarly Bird rate: If you book on or before 6th November 2025\, you will be entitled to the Early Bird rate\, cost as follows: \n£195 for 3 days – Person residing in a low and middle income country\, as defined by DAC list\, at the time of registration.\n£312 for 3 days – University of Nottingham\, School of Medicine student or staff member\n£351 for 3 days – University of Nottingham student or staff member (NOT School of Medicine)\n£351 for 3 days – NHS employee\n£390 for 3 days – anyone who does not fall into any of the categories above \nStandard rate: Any bookings made after 6th November 2025 will be charged as follows: \n£255 for 3 days – Person residing in a low and middle income country\, as defined by DAC list\, at the time of registration.\n£408 for 3 days – University of Nottingham\, School of Medicine student or staff member\n£459 for 3 days – University of Nottingham student or staff member (NOT School of Medicine)\n£459 for 3 days – NHS employee\n£510 for 3 days – anyone who does not fall into any of the categories above \n\nFind out More
URL:https://www.dementiaresearcher.nihr.ac.uk/event/qualitative-methods-in-clinical-trials/
LOCATION:Nottingham Clinical Trials Unit\, Applied Health Research Building\, School of Medicine\, University of Nottingham\, University Park\, Nottingham\, NG7 2RD\, United Kingdom
CATEGORIES:Training
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2025/03/University-of-Nottingham-Logo.png
GEO:52.9421318;-1.1858012
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Nottingham Clinical Trials Unit Applied Health Research Building School of Medicine University of Nottingham University Park Nottingham NG7 2RD United Kingdom;X-APPLE-RADIUS=500;X-TITLE=Applied Health Research Building\, School of Medicine\, University of Nottingham\, University Park:geo:-1.1858012,52.9421318
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251205
DTEND;VALUE=DATE:20251208
DTSTAMP:20260620T055029
CREATED:20250306T202824Z
LAST-MODIFIED:20250310T090143Z
UID:10001691-1764892800-1765151999@www.dementiaresearcher.nihr.ac.uk
SUMMARY:International Symposium on ALS / MND
DESCRIPTION:The International Symposium on ALS/MND is a unique annual event that brings together leading international researchers and health and social care professionals to present and debate key innovations in their respective fields. The Symposium is planned as two parallel meetings\, one on biomedical research and the other on advances in clinical research and treatment of people affected by ALS/MND. Joint sessions consider issues of mutual interest\, challenging current views and practices. \nAbout the Symposium \nThe International Symposium encompasses innovation\, education and collaboration\, as researchers and healthcare professionals come together to update colleagues from across the world on the latest developments in the diagnosis\, treatment and management of ALS/MND. This meeting allows researchers to share the latest information on disease pathology\, clinical practice\, and potential therapeutic targets to a global audience. The Symposium also offers the unique opportunity for researchers to appreciate the reality of the disease from the perspective of the people living with MND\, medical practitioners and caregivers\, to feel part of the whole MND community. \nWhat’s on offer this year? \nThe Symposium Programme Committee\, chaired by Professor Ammar Al-Chalabi\, will consider a broad range of cutting-edge topics for this year’s programme. We will continue to showcase a mix between biomedical research and clinical science\, therapy development and clinical management\, through dedicated oral presentations and poster sessions (which have always been a Symposium highlight). We would encourage as many members of the ALS/MND research and clinical/care communities to join us in-person\, but to remain inclusive to those unable to travel (particularly people living with ALS/MND)\, we are once again offering a virtual option. The virtual option will consist of a selection of live-streamed sessions\, and access to all session recordings post-event (until early March\, 2026). \nWe look forward to welcoming you \nWe hope the Symposium will once again motivate you to make a difference in the work you do for people living with ALS/MND. Last year’s closing session showcased how the latest advancements in technology could help to improve quality of life for people with ALS/MND. The BrainGate Consortium Team was presented with the International Healey Award for Innovation in ALS for their work on Brain Computer Interface (BCI) technology. The development of this technology offers the opportunity to restore communication\, mobility and independence in people living with ALS/MND. This research illustrates hope for the future and the impact research can have on the lives of people with ALS/MND. We hope that this year’s meeting will offer inspiration and the opportunity to stimulate new ideas\, partnerships and collaborations that will lead to further advances in ALS/MND. \nRegistration\nRegistration for in-person attendance will be available from 6 May and registration for those who wish to attend virtually (access the selected live and recorded content only) will be available from 6 September at www.symposium.mndassociation.org/register. A provisional Symposium programme will be available on our website in August. The final programme will be available in November. \nCall for abstracts\nAbstracts must be submitted online\, via a link on the MND Association’s Symposium website (https://www.symposium.mndassociation.org/abstracts). Abstracts cannot be accepted via email. \nAbstracts must be submitted by the presenting author of the abstract\, who must provide an email address to which all Symposium correspondence will be sent. The presenting author is the only person who will receive email correspondence from us. \nSubmissions are limited to two abstracts per presenting author. \nAuthors may submit an abstract for consideration in one of three categories: oral\, poster or work in progress/care practice (WIP/CP) poster presentations. WIP/CP is defined as: preliminary work (little or no data/results)\, care practice or case studies. \nImportant: Authors accepting the offer of an oral or poster presentation must attend the Symposium in-person in San Diego\, USA and be present for their assigned session. \nThe presenting author is not required to fully register for the Symposium before submitting an abstract. However\, formal acceptance of an abstract is conditional upon payment of the appropriate registration fee no later than 5 September 2025. Failure to pay the registration fee by this date will result in withdrawal of the abstract. \nAbstracts must be in English and be no longer than 450 words. The MND Association will not correct any errors\, so authors must ensure their abstract is checked for grammar\, understanding and accuracy. Authors should provide a clear description of methodology and present statistically robust data (including ‘n’ and ‘p’ values) where appropriate. \nAuthors must ensure they have the correct permissions to submit their abstract (e.g. from collaborators and funders). \nThe corresponding oral/poster presentation must discuss the same work as the accepted abstract. \nAbstracts will be published in an open access online supplement to the journal Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. Abstracts accepted as ‘WIP/CP’ will be published on the MND Association’s Symposium website. \nAuthors will also be asked to confirm if the presenting author is eligible and willing to be included in the poster prize competition (see below). The deadline for withdrawing an abstract is 5 September. Abstracts withdrawn after this date will still be published in the journal supplement. \nFull instructions and Conditions of Acceptance will be available on the MND Association’s website before the opening of the submission system on 6 May 2025. These must be read before an abstract is submitted. Queries should be sent to abstracts@ mndassociation.org. \nAbstract submission system opens: 6 May 2025 \nDeadline for abstract submission: 10 July 2025 \nPoster prize\nThe International Symposium on ALS/MND poster prize celebrates early-stage career ALS/MND researchers’ outstanding work\, presented at the conference poster session. \nPrizes will be awarded for the best clinical and best biomedical posters presented at the conference. \nEarly career researchers are eligible to enter if they are aged 35 years or under on the abstract submission deadline date OR if they were awarded their PhD within three years of the abstract submission deadline. \nThe initial stage of judging will be based on the abstracts\, as submitted by the abstract submission deadline of 10 July 2025. Final judging of shortlisted posters will take place at the conference. \nFull terms and conditions for the poster prize will be available on the MND Association’s website (https://www.symposium.mndassociation.org/for-presenters/poster-prize) following the opening of the abstract submission system in May 2025.
URL:https://www.dementiaresearcher.nihr.ac.uk/event/international-symposium-on-als-mnd/
LOCATION:Loews Coronado Bay Resort\, 4000 Coronado Bay Road\, Coronado\, San Diego\, 92118\, United States
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2025/03/36th-International-Symposium-on-ALS-MND.png
ORGANIZER;CN="MND Association":MAILTO:fundraising@mndassociation.org
GEO:32.6319231;-117.1343534
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Loews Coronado Bay Resort 4000 Coronado Bay Road Coronado San Diego 92118 United States;X-APPLE-RADIUS=500;X-TITLE=4000 Coronado Bay Road:geo:-117.1343534,32.6319231
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251205T090000
DTEND;TZID=Europe/London:20251205T100000
DTSTAMP:20260620T055029
CREATED:20251118T083832Z
LAST-MODIFIED:20251118T083832Z
UID:10001996-1764925200-1764928800@www.dementiaresearcher.nihr.ac.uk
SUMMARY:LGBTQIAP2S+ Dementia Forum
DESCRIPTION:As 2025 draws to a close\, our first ‘LGBTQIAP2S+ Dementia Forum‘ in the Dementia Researcher Community is for those interested in the field\, meeting to chat and take a critical look at where queer-inclusive dementia research has advanced\, and where it has been pushed backwards over the past year.  \n\n\nAlongside this\, we will spotlight innovative international research that is reshaping how we think about dementia\, identity\, care\, and equity. Expect frank discussion\, lived experience\, and constructive provocations. \nNo slides\, no pressure—just open conversation and shared insight. \nOpen\, respectful participation welcome. \n\n\nJoin Us
URL:https://www.dementiaresearcher.nihr.ac.uk/event/lgbtqiap2s-dementia-forum/
LOCATION:Dementia Researcher Communities App
CATEGORIES:Forum
ATTACH;FMTTYPE=image/png:https://www.dementiaresearcher.nihr.ac.uk/wp-content/uploads/2025/11/LGBTQIAP2S-Forum-Web-280-x-280-px.png
END:VEVENT
END:VCALENDAR